You just read:

CASI Pharmaceuticals Announces China National Medical Products Administration (NMPA) Approval Of CTA To Conduct Registration Trial For MARQIBO®

News provided by

CASI Pharmaceuticals, Inc.

Mar 07, 2019, 07:00 ET